Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment

Completed · Phase 2

Conditions studied: HIV Infections

In brief

The purpose of this study is to see if it is safe and effective to give adefovir dipivoxil plus abacavir (ABC) plus efavirenz (EFV) plus amprenavir (APV) to HIV-infected patients who have failed to respond to previous treatment with protease inhibitors (PIs).

Key facts

Study ID

NCT00002419

Run by

Gilead Sciences

People needed

25

Last updated by the study team

2005-06-24

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• You may be eligible for this study if you:
• Are HIV-positive.
• Had an HIV level of at least 2,000 copies/ml after 6 months of treatment with at least 1 PI other than amprenavir (meaning you failed PI treatment).
• Are at least 13 years old (need consent of parent or guardian if under 18).
• Are able to complete the study.
• Agree to use effective barrier methods of birth control, such as condoms, during the study.

You may not qualify if…

• You will not be eligible for this study if you:
• Have certain serious medical conditions, including AIDS-related cancers (except Kaposi's sarcoma) that require treatment during the study.
• Have ever taken or are allergic to adefovir dipivoxil, ABC, APV, EFV.
• Are participating in another anti-HIV drug trial during this study.
• Have taken certain medications within 30 days prior to study entry, including medications that affect your immune system.
• Have been diagnosed with hepatitis within the past 30 days.
• Abuse alcohol or drugs.
• Are pregnant or breast-feeding.
• Have ever taken NNRTIs.
• Have ever taken ddI or d4T.
• Have received chemotherapy or radiation therapy within 30 days prior to study entry.

Where it is running

• Pacific Oaks Med Group — Beverly Hills, California, United States
• Univ of Colorado / Health Science Ctr — Denver, Colorado, United States
• AIDS Research Consortium of Atlanta — Atlanta, Georgia, United States
• Brown Univ School of Medicine — Providence, Rhode Island, United States
• Hampton Roads Med Specialists — Hampton, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.